Clinical trial
Flibanserin Randomized Withdrawal Trial in Pre-menopausal Women
NCT00277914 · Sprout Pharmaceuticals, Inc, Industry · Completed
Key facts
| NCT number | NCT00277914 |
|---|---|
| Title | Flibanserin Randomized Withdrawal Trial in Pre-menopausal Women |
| Official title | 12-month Sustained Efficacy of Flibanserin v Placebo n Younger Women With HSDD in NA |
| Lead sponsor | Sprout Pharmaceuticals, Inc, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sexual Dysfunctions, Psychological |
| Intervention type | Drug |
| Interventions | Flibanserin |
| Enrollment | 749 |
| Start date | Jan 1, 2006 |
| Primary completion | Jul 1, 2007 |
| First posted | Jan 18, 2006 |
| Last update posted | Mar 16, 2012 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: